Summary
Gaschromatography — mass spectrometry (GC/MS) was used to determine plasma levels of oxcarbazepine (OCB) and its main metabolite in a newborn girl and her OCB-treated mother during the first five post partum days.
At delivery the maternal and neonatal plasma concentrations were in the same range, indicating considerable placental transfer of both substances. In spite of ingestion of both substances via breast milk, there was no accumulation in the baby. On the fifth post partum day OCB and 10-hydroxy-carbazepine (10-OH-CB) levels in plasma in the newborn were only 12 and 7%, respectively, of the values found on the first day after delivery.
This is a preview of subscription content, log in via an institution to check access.
References
Sillanpää M (1981) Carbamazepine. Pharmacology and clinical uses. Acta Neurol Scand 64 [Suppl 88]: 1–202
Krämer G, Theisohn M, Stoll KD, Wendt G (1985) Oxcarbazepin versus Carbamazepin bei gesunden Probanden. Studien zur Kinetik, zu Metabolismus und Verträglichkeit. In: Kruse R (ed) Epilepsie 84. Einhorn, Berlin, pp 379–387
Bülau P, Stoll KD, Fröscher W (1987) Oxcarbazepine versus carbamazepine. In: Wolf P, Dam M, Janz D, Dreifuss F (eds) Advances in epileptology, vol 16. Raven Press, New York, pp 531–536
Eichelbaum M, Tomson T, Tybring G, Bertilsson L (1985) Carbamazepine metabolism in man — Induction and pharmacogenetic aspects. Clin Pharmacokinet 10: 80–90
Lindhout D, Höppener RJEA, Meinardi H (1984) Teratogenecity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine). Epilepsia 25: 77–83
von Unruh GE, Paar WD (1986) Gas chromatographic mass spectrometric assays for oxcarbazepine and its main metabolites, 10-hydroxy-carbazepine and carbazepine-10, 11-transdiol. Biomed Env Mass Spectrom 13: 651–656
Nau H, Kuhnz W, Egger HJ, Rating D, Helge H (1982) Anticonvulsants during pregnancy and lactation — Transplacental, maternal and neonatal pharmacokientics. Clin Pharmacokinet 7: 508–543
Fröscher W, Eichelbaum M, Niesen M, Dietrich K, Rausch P (1984) Carbamazepine levels in breast milk. Ther Drug Monit 6: 266–271
Wagner JG, Northam JI, Alway CD, Carpenter OS (1965) Blood levels of drug at the equilibrium state after multiple dosing. Nature 207: 1301–1302
Palitzsch D (1983) Pädiatrie. Enke, Stuttgart
Kristensen O, Klitgaard NA, Jönsson B, Sindrup S (1983) Pharmacokinetics of 10-OH-carbazepine, the main metabolite of the antiepileptic oxcarbazepine, from serum and saliva concentrations. Acta Neurol Scand 68: 145–150
Feldmann KF, Dörhöfer G, Faigle JW, Imhof P (1981) Pharmacokinetics and metabolism of GP 47779, the main human metabolite of oxcarbazepine (GP 47680) in animals and healthy volunteers. In: Dam M, Gram L, Penry JK (eds) Advances in epileptology: XIIth Epilepsy International Symposium. Raven Press, New York, pp 89–96
Rane A, Bertilsson L, Palmér L (1975) Disposition of placentally transferred carbamazepine (Tegretol) in the newborn. Eur J Clin Pharmacol 8: 283–284
Theisohn M, Heimann G (1982) Disposition of the antiepileptic oxcarbazepine and its metabolites in healthy volunteers. Eur J Clin Pharmacol 22: 545–551
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bülau, P., Paar, W.D. & von Unruh, G.E. Pharmacokinetics of oxcarbazepine and 10-hydroxy-carbazepine in the newborn child of an oxcarbazepine-treated mother. Eur J Clin Pharmacol 34, 311–313 (1988). https://doi.org/10.1007/BF00540963
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00540963